StockData
biote Corp. logo

biote Corp. (BTMD) stock

BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3069% below fair value
$0.99+0.03 (+3.09%)

Close on Nov 17, 2026Market cap $35.57MP/E 9.9Yield –

biote cash

Cash and short-term investments held at the end of each period.

biote's cash was $11.17M at Jun 30, 2026. For fiscal 2025 it was $24.12M, down 38.7% from the year before. The highest annual figure on record is $89.00M in fiscal 2023.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$24.12M-38.7%
FY2024Dec 31, 2024$39.34M-55.8%
FY2023Dec 31, 2023$89.00M+12.3%
FY2022Dec 31, 2022$79.23M+196.0%
FY2021Dec 31, 2021$26.77M+1679071.9%
FY2020Dec 31, 2020$1.59K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$11.17M-43.0%
Q1 FY2026Mar 31, 2026$5.32M-87.2%
Q4 FY2025Dec 31, 2025$24.12M-38.7%
Q3 FY2025Sep 30, 2025$28.05M-26.6%
Q2 FY2025Jun 30, 2025$19.60M-25.8%
Q1 FY2025Mar 31, 2025$41.70M-47.1%
Q4 FY2024Dec 31, 2024$39.34M-55.8%
Q3 FY2024Sep 30, 2024$38.23M-55.3%
Q2 FY2024Jun 30, 2024$26.42M-70.1%
Q1 FY2024Mar 31, 2024$78.79M-10.1%
Q4 FY2023Dec 31, 2023$89.00M+12.3%
Q3 FY2023Sep 30, 2023$85.58M+10.5%
Q2 FY2023Jun 30, 2023$88.48M+7.0%
Q1 FY2023Mar 31, 2023$87.61M+128928.8%
Q4 FY2022Dec 31, 2022$79.23M+196.0%
Q3 FY2022Sep 30, 2022$77.46M+26165.3%
Q2 FY2022Jun 30, 2022$82.73M+16988.8%
Q1 FY2022Mar 31, 2022$67.90K-92.6%
Q4 FY2021Dec 31, 2021$26.77M+1679071.9%
Q3 FY2021Sep 30, 2021$294.92K+117867.2%
Q2 FY2021Jun 30, 2021$484.09K–
Q1 FY2021Mar 31, 2021$922.48K–
Q4 FY2020Dec 31, 2020$1.59K–
Q3 FY2020Sep 30, 2020$250–

More biote figures

See a number that looks wrong?